So GSK...gets the nod on M to M on 85% reduction i

So GSK...gets the nod on M to M on 85% reduction in mortality and hospitalization NOW...and yet months ago...we get an 82% reduction and WE get the cold shoulder. The FDA goes further and suggests Monoclonal Antibodies may make things worse...and that GSK's product is NOT effective against Covid-19...Is the EUA ...an applause or a back-handed slap...they go on to say "it could" be beneficial. YES,..NO...or maybe So?...starting to sound more like Dr. Tony "The Chameleon" Faustus.